News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
113 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25071)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (202)
2 (163)
3 (150)
4 (1)
6 (113)
7 (192)
8 (195)
9 (146)
10 (94)
11 (1)
12 (5)
13 (183)
14 (272)
15 (209)
16 (183)
17 (86)
18 (3)
19 (5)
20 (142)
21 (207)
22 (173)
23 (165)
24 (67)
25 (3)
26 (3)
27 (139)
28 (227)
29 (177)
30 (210)
31 (85)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Diplomat Announces 2nd Quarter Financial Results
2nd Quarter Revenue of $1,416 Million, an increase of 26%, Net (Loss) Income Attributable to Diplomat of $(4.0) Million compared to $3.6 Million, Adjusted EBITDA of $42.7 Million, an increase of 70%
August 6, 2018
·
49 min read
Business
Jazz Pharmaceuticals and MD Anderson Cancer Center Collaborate to Evaluate Potential Treatment Options for Hematologic Malignancies
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) and The University of Texas MD Anderson Cancer Center today announced a five-year collaboration agreement with a goal of evaluating therapies for multiple hematologic malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes.
August 6, 2018
·
7 min read
BioMidwest
Teledyne ISCO Announces Update to Popular CombiFlash Line of Flash Chromatography Systems
CombiFlash NextGen’s Three New Models Offer Smaller Footprint and Greener Use
August 6, 2018
·
3 min read
Business
RMS Medical Products Announces Record Quarterly Sales and Net Income
Net Sales for the quarter ended June 30, 2018 increased 17.6% over the same period last year
August 6, 2018
·
22 min read
Deals
Sotera Health’s Nordion completes the sale of its medical isotopes business to BWXT
Nordion’s increased focus on gamma technologies supports Sotera Health’s company-wide commitment to Safeguarding Global Health™
August 6, 2018
·
2 min read
Deals
GI Partners Completes Acquisition and Merger of California Cryobank and Cord Blood Registry
GI Partners announced today that it has completed the previously announced acquisition and merger of California Cryobank (CCB), the world’s premier donor sperm and egg bank, and Cord Blood Registry (CBR), the world’s largest stem cell collection and storage company.
August 6, 2018
·
2 min read
Policy
Fluidic Analytics Secures US Patent for Fluidic Separation and Detection Technology
Fluidic Analytics Ltd, has announced the issuance of US Patent 9,952,22 B2, entitled ‘Fluidic Separation and Detection’, from the United States Patent and Trademark Office.
August 6, 2018
·
2 min read
Business
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement for the North American Development and Commercialization of Trofinetide in Rett Syndrome
ACADIA plans to initiate a Phase 3 study of trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental congenital CNS disorder, in the second half of 2019
August 6, 2018
·
10 min read
Biotech Bay
Nurx Launches In Tennessee, Offering Home Delivery Of Affordable Birth Control And HIV Prevention
Telemedicine Platform Expands Access to Prescription Birth Control and PrEP for HIV Prevention To Combat Tennessee’s Unintended Pregnancy Rate and HIV Cases
August 6, 2018
·
4 min read
Deals
Rite Aid and Albertsons Announce Deadline for Election of Form of Consideration
Rite Aid Corporation and Albertsons Companies, Inc. announced that, in connection with the pending merger between Albertsons and Rite Aid, the election deadline for holders of shares of Rite Aid common stock is 5:00 p.m. Eastern Time on August 13, 2018.
August 6, 2018
·
9 min read
Previous
10 of 12
Next